Revelation Biosciences Inc (REVB)
2.37
+0.02
(+0.85%)
USD |
NASDAQ |
May 03, 16:00
2.30
-0.07
(-2.95%)
Pre-Market: 20:00
Revelation Biosciences Market Cap: 3.87M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.87M |
| May 02, 2024 | 3.837M |
| May 01, 2024 | 3.511M |
| April 30, 2024 | 3.441M |
| April 29, 2024 | 3.462M |
| April 26, 2024 | 3.560M |
| April 25, 2024 | 3.494M |
| April 24, 2024 | 3.413M |
| April 23, 2024 | 3.380M |
| April 22, 2024 | 3.347M |
| April 19, 2024 | 3.658M |
| April 18, 2024 | 3.658M |
| April 17, 2024 | 3.511M |
| April 16, 2024 | 3.119M |
| April 15, 2024 | 2.98M |
| April 12, 2024 | 3.396M |
| April 11, 2024 | 3.788M |
| April 10, 2024 | 3.772M |
| April 09, 2024 | 3.968M |
| April 08, 2024 | 4.246M |
| April 05, 2024 | 4.360M |
| April 04, 2024 | 4.442M |
| April 03, 2024 | 4.246M |
| April 02, 2024 | 4.229M |
| April 01, 2024 | 4.344M |
| Date | Value |
|---|---|
| March 28, 2024 | 4.474M |
| March 27, 2024 | 3.968M |
| March 26, 2024 | 4.246M |
| March 25, 2024 | 3.903M |
| March 22, 2024 | 3.87M |
| March 21, 2024 | 4.001M |
| March 20, 2024 | 3.968M |
| March 19, 2024 | 3.723M |
| March 18, 2024 | 3.903M |
| March 15, 2024 | 0.9553M |
| March 14, 2024 | 0.9355M |
| March 13, 2024 | 1.031M |
| March 12, 2024 | 1.237M |
| March 11, 2024 | 1.332M |
| March 08, 2024 | 1.348M |
| March 07, 2024 | 1.348M |
| March 06, 2024 | 1.189M |
| March 05, 2024 | 1.264M |
| March 04, 2024 | 1.352M |
| March 01, 2024 | 1.443M |
| February 29, 2024 | 1.447M |
| February 28, 2024 | 1.633M |
| February 27, 2024 | 1.360M |
| February 26, 2024 | 1.253M |
| February 23, 2024 | 1.110M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
0.8158M
Minimum
Feb 02 2024
119.46M
Maximum
Jan 12 2022
9.024M
Average
5.722M
Median
Oct 17 2022
Market Cap Benchmarks
| Cardiff Oncology Inc | 157.26M |
| Ocular Therapeutix Inc | 917.03M |
| Ocugen Inc | 342.25M |
| Cue Biopharma Inc | 103.61M |
| Solid Biosciences Inc | 382.39M |
Market Cap Related Metrics
| PE Ratio | 0.078 |
| Price to Book Value | 0.5822 |
| Price | 2.37 |
| Earnings Yield | 1.28K% |